Cytotoxicity mediated by the Fas ligand (FasL)-activated apoptotic pathway in stem cells

Julia Mazar, Molly Thomas, Ludmila Bezrukov, Alexander Chanturia, Gulcin Pekkurnaz, Shurong Yin, Sergei A. Kuznetsov, Pamela G. Robey, Joshua Zimmerberg

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Abstract

Whereas it is now clear that human bone marrow stromal cells (BMSCs) can be immunosuppressive and escape cytotoxic lymphocytes (CTLs) in vitro and in vivo, the mechanisms of this phenomenon remain controversial. Here, we test the hypothesis that BMSCs suppress immune responses by Fas-mediated apoptosis of activated lymphocytes and find both Fas and FasL expression by primary BMSCs. Jurkat cells or activated lymphocytes were each killed by BMSCs after 72 h of co-incubation. In comparison, the cytotoxic effect of BMSCs on non-activated lymphocytes and on caspase-8(-/-) Jurkat cells was extremely low. Fas/Fc fusion protein strongly inhibited BMSC-induced lymphocyte apoptosis. Although we detected a high level of Fas expression in BMSCs, stimulation of Fas with anti-Fas antibody did not result in the expected BMSC apoptosis, regardless of concentration, suggesting a disruption of the Fas activation pathway. Thus BMSCs may have an endogenous mechanism to evade Fas-mediated apoptosis. Cumulatively, these data provide a parallel between adult stem/progenitor cells and cancer cells, consistent with the idea that stem/progenitor cells can use FasL to prevent lymphocyte attack by inducing lymphocyte apoptosis during the regeneration of injured tissues.

Original languageEnglish
Pages (from-to)22022-22028
Number of pages7
JournalJournal of Biological Chemistry
Volume284
Issue number33
DOIs
StatePublished - 14 Aug 2009
Externally publishedYes

Fingerprint

Dive into the research topics of 'Cytotoxicity mediated by the Fas ligand (FasL)-activated apoptotic pathway in stem cells'. Together they form a unique fingerprint.

Cite this